J. Christopher Naftzger - General Counsel and CCO at Arbutus Biopharma Corp

Insider Transactions and Holdings

Entity Type
Individual
Role
General Counsel and CCO
Issuer Symbol
ABUS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by J. Christopher Naftzger since 15 Feb 2025

Holdings reported by J. Christopher Naftzger for Arbutus Biopharma Corp

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 220,300 $1,069,205 $2.81 14 Feb 2025 Direct Common Shares
Common Shares 140,544 $461,406 $3.28 14 Feb 2025 Direct

Transactions reported by J. Christopher Naftzger for Arbutus Biopharma Corp

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.